Delivery Order SPE2DB25D7056-SPE2DB25FTMAC

Award Date 2/27/25
Potential Completion Date 2/28/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,082.98 contract is for the supply of 4,564,313,014 units of 200 mg Progesterone capsules. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through 2025, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical products...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,439.62, is for the delivery of 4,567,237,046 units of Progesterone 200 mg capsules in 100-count bottles. The contract type is Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is February 12, 2025. The contract is not designated as a set-aside. In...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,410 units of Progesterone 200 mg capsules. The contract is a firm fixed-price delivery order with a ceiling value of $12,670.26 and an ultimate completion date of February 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the procurement of 4567330905 - Progesterone 200 mg Capsule, 100s, with a ceiling value of $22,834.68 and a period of performance through February 21, 2025. The contract is a firm fixed-price vehicle with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $18,873.69 and is for the delivery of 4,567,422,816 units of Progesterone 100 mg Capsules in 100-count bottles. The contract is a Firm Fixed Price (FFP) type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Progesterone 200 mg capsules. The contract has a ceiling value of $2,204.51 and a completion date of January 27, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,652.00, is for the delivery of 4567415101 - Progesterone 200 mg Capsule 100s. It is a firm fixed price contract that runs through February 26, 2025. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,163.42 firm fixed-price contract is for the delivery of 4,567,074,528 units of progesterone 100 mg capsules over a period ending on January 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Progesterone 200 mg capsules and has a ceiling value of $1,815.42. The contract has an ultimate completion date of April 2, 2024 and was awarded on April 1, 2024. This delivery order is...
This federal contract award, valued at $1,476.64, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565058884 - Progesterone 200 mg Capsule 100s, a pharmaceutical product. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
  • SPE2DB25D7056
    Indefinite Delivery Contract
  • SPE2DB25D7056-SPE2DB25FTMAC
    Delivery Order

This is a delivery order issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $12,459.36. The contract is for the supply of 4,567,395,293 units of Progesterone 200 mg capsules in 100-count bottles. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a larger IDC with the DLA valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/1/25, 2:50 AM